Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis

OBJECTIVE: Treatment of relapses in multiple sclerosis (MS) has not advanced beyond steroid use, which reduces acute loss of function, but has little effect on residual disability. Acute loss of function in an MS model (experimental autoimmune encephalomyelitis [EAE]) is partly due to central nervou...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Roshni A., Davies, Andrew L., Del Rossi, Natalie, Tachrount, Mohamed, Dyson, Alex, Gustavson, Britta, Kaynezhad, Pardis, Mackenzie, Lewis, van der Putten, Marieke A., McElroy, Daniel, Schiza, Dimitra, Linington, Christopher, Singer, Mervyn, Harvey, Andrew R., Tachtsidis, Ilias, Golay, Xavier, Smith, Kenneth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737229/
https://www.ncbi.nlm.nih.gov/pubmed/32293054
http://dx.doi.org/10.1002/ana.25749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737229/
https://www.ncbi.nlm.nih.gov/pubmed/32293054
http://dx.doi.org/10.1002/ana.25749

Ejemplares similares